Beroni Group has provided an update on the development of the previously announced potential medical solution utilizing nanobody technology for both detection and treatment of COVID-19 in collaboration with Tianjin University in China.
Belgian biotech Ablynx just signed a potentially lucrative new deal with Sanofi that could be worth an eye-watering €2.4 billion, although just €23 million of that comes up front.